Search research articles
Contact Us
Filters
Showing results (391-400 of 583) with videos related to
Page
of 59
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
January 21, 2004
Serial MRI in multiple sclerosis: a prospective pilot study of lesion load, whole brain volume and thalamic atrophy
I Taylor, H Butzkueven, L Litewka, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
Generation of an inducible destabilized-domain Cre mouse line to target disease associated microglia
Caden M Henningfield, Nellie Kwang, Kate Inman Tsourmas, et al.
Journal of Huntington'S Disease
|
July 9, 2013
Age-Dependent Resistance to Excitotoxicity in Htt CAG140 Mice and the Effect of Strain Background
Melissa K Strong, Amber L Southwell, Jennifer M Yonan, et al.
British Medical Journal (Clinical Research Ed.)
|
February 9, 1985
Prescribing: the power to set limits
J M Harding, M Modell, S Freudenberg, et al.
Basic & Clinical Pharmacology & Toxicology
|
October 28, 2010
Concomitant administration of BILR 355/r with emtricitabine/tenofovir disoproxil fumarate increases exposure to emtricitabine and tenofovir: a randomized, open-label, prospective study
Fenglei Huang, Paul Scholl, David B Huang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1992
Is [1-11C]putrescine useful as a brain tumor marker?
E M Hiesiger, J S Fowler, J Logan, et al.
Experimental Brain Research
|
January 1, 1982
Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography
A Alavi, M Reivich, S Ferris, et al.
Biochemical and Biophysical Research Communications
|
July 30, 2005
Purification of normal cellular prion protein from human platelets and the formation of a high molecular weight prion protein complex following platelet activation
Michael Jones, Mark W Head, John G Connolly, et al.
Biopharmaceutics & Drug Disposition
|
March 4, 2000
Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers
M J Lamson, J P Sabo, T R MacGregor, et al.
BMC Neurology
|
June 26, 2007
'MRI-negative PET-positive' temporal lobe epilepsy (TLE) and mesial TLE differ with quantitative MRI and PET: a case control study
Ross P Carne, Terence J O'Brien, Christine J Kilpatrick, et al.
Page
of 59
Search research articles
Search
Showing results (391-400 of 583) with videos related to
Sort By:
Page
of 59
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
January 21, 2004
Serial MRI in multiple sclerosis: a prospective pilot study of lesion load, whole brain volume and thalamic atrophy
I Taylor, H Butzkueven, L Litewka, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
Generation of an inducible destabilized-domain Cre mouse line to target disease associated microglia
Caden M Henningfield, Nellie Kwang, Kate Inman Tsourmas, et al.
Journal of Huntington'S Disease
|
July 9, 2013
Age-Dependent Resistance to Excitotoxicity in Htt CAG140 Mice and the Effect of Strain Background
Melissa K Strong, Amber L Southwell, Jennifer M Yonan, et al.
British Medical Journal (Clinical Research Ed.)
|
February 9, 1985
Prescribing: the power to set limits
J M Harding, M Modell, S Freudenberg, et al.
Basic & Clinical Pharmacology & Toxicology
|
October 28, 2010
Concomitant administration of BILR 355/r with emtricitabine/tenofovir disoproxil fumarate increases exposure to emtricitabine and tenofovir: a randomized, open-label, prospective study
Fenglei Huang, Paul Scholl, David B Huang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1992
Is [1-11C]putrescine useful as a brain tumor marker?
E M Hiesiger, J S Fowler, J Logan, et al.
Experimental Brain Research
|
January 1, 1982
Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography
A Alavi, M Reivich, S Ferris, et al.
Biochemical and Biophysical Research Communications
|
July 30, 2005
Purification of normal cellular prion protein from human platelets and the formation of a high molecular weight prion protein complex following platelet activation
Michael Jones, Mark W Head, John G Connolly, et al.
Biopharmaceutics & Drug Disposition
|
March 4, 2000
Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers
M J Lamson, J P Sabo, T R MacGregor, et al.
BMC Neurology
|
June 26, 2007
'MRI-negative PET-positive' temporal lobe epilepsy (TLE) and mesial TLE differ with quantitative MRI and PET: a case control study
Ross P Carne, Terence J O'Brien, Christine J Kilpatrick, et al.
Page
of 59